Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17369631 | 0.81 | SIGMAR1 (0.45) | SIGMAR1HTR2CHTT | |
| SCHEMBL104225 | 0.81 | — | — | |
| SCHEMBL13884246 | 0.81 | SIGMAR1 (0.45) | SIGMAR1HTR2CHTT | |
| SCHEMBL104945 | 0.81 | KDM4E (0.40) | SIGMAR1HTR2C | |
| Hydrochloric Acid SCHEMBL21879609 | 0.79 | — | — | |
| SCHEMBL105260 | 0.79 | HTT (0.41) | SIGMAR1HTR2CHTT | |
| SCHEMBL104968 | 0.79 | — | — | |
| SCHEMBL14176594 | 0.77 | ADH1B (0.44) | SIGMAR1HTT | |
| SCHEMBL22899465 | 0.77 | ADH1B (0.44) | SIGMAR1HTT | |
| SCHEMBL104714 | 0.77 | ADH1B (0.44) | SIGMAR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | HVCN1, TRPM8, TRPM2 | SIGMAR1 1764/4885HTR2C 1814/4885HTT 2241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.